EGFR and breast cancer: Recently, we have shown that NBD compounds bind to the extracellular region of EGFR and enhance tyrosine phosphorylation of EGFR, leading to aberrant triggering of downstream and lateral signaling in breast cancer and non-small lung cancer cells29.